Functional analysis of the stem-loop structures at the 5' end of the Aichi virus genome.

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 12951021)

Published in Virology on August 15, 2003

Authors

Shigeo Nagashima1, Jun Sasaki, Koki Taniguchi

Author Affiliations

1: Department of Virology and Parasitology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.

Articles citing this

The complete genome of klassevirus - a novel picornavirus in pediatric stool. Virol J (2009) 2.46

Isolation and molecular characterization of Aichi viruses from fecal specimens collected in Japan, Bangladesh, Thailand, and Vietnam. J Clin Microbiol (2007) 2.45

The 5'-terminal region of the Aichi virus genome encodes cis-acting replication elements required for positive- and negative-strand RNA synthesis. J Virol (2005) 1.08

Aichi virus 2A protein is involved in viral RNA replication. J Virol (2008) 0.94

Valosin-containing protein (VCP/p97) is required for poliovirus replication and is involved in cellular protein secretion pathway in poliovirus infection. J Virol (2012) 0.91

Evidence of pervasive biologically functional secondary structures within the genomes of eukaryotic single-stranded DNA viruses. J Virol (2013) 0.88

Interaction between polypeptide 3ABC and the 5'-terminal structural elements of the genome of Aichi virus: implication for negative-strand RNA synthesis. J Virol (2008) 0.85

A complex comprising phosphatidylinositol 4-kinase IIIβ, ACBD3, and Aichi virus proteins enhances phosphatidylinositol 4-phosphate synthesis and is critical for formation of the viral replication complex. J Virol (2014) 0.83

Crucial role of the 5' conserved structure of bamboo mosaic virus satellite RNA in downregulation of helper viral RNA replication. J Virol (2006) 0.83

A 5'-proximal stem-loop structure of 5' untranslated region of porcine reproductive and respiratory syndrome virus genome is key for virus replication. Virol J (2011) 0.81

Articles by these authors

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet (2007) 9.56

Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87

Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77

Preventive effects of eicosapentaenoic acid on coronary artery disease in patients with peripheral artery disease. Circ J (2010) 2.13

Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol (2006) 2.12

Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J (2009) 2.01

Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb (2007) 1.70

Anabaena sensory rhodopsin: a photochromic color sensor at 2.0 A. Science (2004) 1.58

Two patients with acute rotavirus encephalitis associated with cerebellar signs and symptoms. Eur J Pediatr (2010) 1.50

Prevalence of metabolic syndrome in the general Japanese population in 2000. J Atheroscler Thromb (2006) 1.50

Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb (2007) 1.45

Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -2012 version. J Atheroscler Thromb (2013) 1.42

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis (2008) 1.37

Reverse genetics system for introduction of site-specific mutations into the double-stranded RNA genome of infectious rotavirus. Proc Natl Acad Sci U S A (2006) 1.37

The 5'-end sequence of the genome of Aichi virus, a picornavirus, contains an element critical for viral RNA encapsidation. J Virol (2003) 1.36

Characterization of human rotavirus strains with G12 and P[9] detected in Japan. J Med Virol (2004) 1.35

ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J (2011) 1.35

Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke (2008) 1.29

Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis (2009) 1.28

Complete nucleotide sequences of two RNA segments of human picobirnavirus. J Virol Methods (2005) 1.24

A dried blood sample on filter paper is suitable for detecting Plasmodium falciparum gametocytes by reverse transcription polymerase chain reaction. Acta Trop (2008) 1.22

Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis. Pediatrics (2008) 1.21

Rotavirus nonstructural protein 1 suppresses virus-induced cellular apoptosis to facilitate viral growth by activating the cell survival pathways during early stages of infection. J Virol (2010) 1.18

Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese adults. J Atheroscler Thromb (2002) 1.17

High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. J Virol (2006) 1.16

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J (2002) 1.15

Relationships between plasma fatty acid composition and coronary artery disease. J Atheroscler Thromb (2010) 1.11

Photochromicity of Anabaena sensory rhodopsin, an atypical microbial receptor with a cis-retinal light-adapted form. J Biol Chem (2005) 1.09

The 5'-terminal region of the Aichi virus genome encodes cis-acting replication elements required for positive- and negative-strand RNA synthesis. J Virol (2005) 1.08

Porcine rotavirus closely related to novel group of human rotaviruses. Emerg Infect Dis (2011) 1.08

Aichi virus leader protein is involved in viral RNA replication and encapsidation. J Virol (2003) 1.07

Metabolic syndrome. J Atheroscler Thromb (2008) 1.06

Serum lipid survey and its recent trend in the general Japanese population in 2000. J Atheroscler Thromb (2005) 1.03

Japanese dietary lifestyle and cardiovascular disease. J Atheroscler Thromb (2011) 1.02

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J (2002) 1.00

Norovirus storm in Osaka, Japan, last winter (2006/2007). Jpn J Infect Dis (2007) 0.97

Radiologic features of uterine lipoleiomyoma. J Comput Assist Tomogr (2003) 0.96

Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients. Circ J (2003) 0.95

The molecular chaperone heat shock protein-90 positively regulates rotavirus infectionx. Virology (2009) 0.95

Physical activity in the Japan population: association with blood lipid levels and effects in reducing cardiovascular and all-cause mortality. J Atheroscler Thromb (2011) 0.95

Human group B rotavirus infections cause severe diarrhea in children and adults in Bangladesh. J Clin Microbiol (2003) 0.94

Aichi virus 2A protein is involved in viral RNA replication. J Virol (2008) 0.94

Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese. J Atheroscler Thromb (2007) 0.92

Attractant and repellent signaling conformers of sensory rhodopsin-transducer complexes. Biochemistry (2010) 0.92

Immunohistochemical observation of canine degenerative myelopathy in two Pembroke Welsh Corgi dogs. J Vet Med Sci (2011) 0.92

A Schiff base connectivity switch in sensory rhodopsin signaling. Proc Natl Acad Sci U S A (2008) 0.92

Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison. Arzneimittelforschung (2002) 0.91

Ultrasonographic features of the masseter muscle in female patients with temporomandibular disorder associated with myofascial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2004) 0.91

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia. Atherosclerosis (2002) 0.91

Familial hypercholesterolemia. J Atheroscler Thromb (2013) 0.91

Genetic analysis of group B human rotaviruses detected in Bangladesh in 2000 and 2001. J Med Virol (2004) 0.90

Resonance Raman spectroscopy and quantum chemical calculations reveal structural changes in the active site of photoactive yellow protein. Biochemistry (2002) 0.90

Time-resolved detection of sensory rhodopsin II-transducer interaction. Biophys J (2004) 0.90

A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease. Atherosclerosis (2004) 0.89

Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric patients. Vaccine (2012) 0.88

Laser-induced transient grating analysis of dynamics of interaction between sensory rhodopsin II D75N and the HtrII transducer. Biophys J (2006) 0.88

Generation of recombinant rotavirus with an antigenic mosaic of cross-reactive neutralization epitopes on VP4. J Virol (2008) 0.88

Comprehensive risk management for the prevention of cardiovascular disease: executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan -- 2012. J Atheroscler Thromb (2013) 0.88

Successful surgical repair of a bilateral coronary-to-pulmonary artery fistula. Ann Thorac Cardiovasc Surg (2009) 0.87

Isolation of human monoclonal antibodies that neutralize human rotavirus. J Virol (2004) 0.87

Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study. J Atheroscler Thromb (2002) 0.87

Pathological and immunohistochemical study of chickens with co-infection of Marek's disease virus and chicken anaemia virus. Avian Pathol (2009) 0.86

Diabetes mellitus. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb (2013) 0.86

HAMP domain signal relay mechanism in a sensory rhodopsin-transducer complex. J Biol Chem (2012) 0.86

Goals of dyslipidemia management. J Atheroscler Thromb (2007) 0.85

Detection and characterization of human group C rotaviruses in Bangladesh. J Clin Microbiol (2005) 0.85

Structural changes of sensory rhodopsin I and its transducer protein are dependent on the protonated state of Asp76. Biochemistry (2008) 0.85

A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2. Vaccine (2008) 0.85

Signal transmission through the HtrII transducer alters the interaction of two alpha-helices in the HAMP domain. J Mol Biol (2007) 0.85

Interaction between polypeptide 3ABC and the 5'-terminal structural elements of the genome of Aichi virus: implication for negative-strand RNA synthesis. J Virol (2008) 0.85

Expression and antigenicity of virus-like particles of norovirus and their application for detection of noroviruses in stool samples. J Med Virol (2005) 0.84

Close relationship between G8-serotype bovine and human rotaviruses isolated in Nigeria. J Clin Microbiol (2003) 0.84

Osteopontin participates in Th1-mediated host resistance against nonlethal malaria parasite Plasmodium chabaudi chabaudi infection in mice. Infect Immun (2006) 0.84

Isolation of cross-reactive human monoclonal antibodies that prevent binding of human noroviruses to histo-blood group antigens. J Med Virol (2013) 0.84

Whole genomic analysis of a porcine-like human G5P[6] rotavirus strain isolated from a child with diarrhoea and encephalopathy in Japan. J Gen Virol (2013) 0.84

Active participation of cellular chaperone Hsp90 in regulating the function of rotavirus nonstructural protein 3 (NSP3). J Biol Chem (2011) 0.83

Abnormal development of nephrons in claudin-16-defective Japanese black cattle. J Vet Med Sci (2005) 0.83

A role of methionine 100 in facilitating PYP(M)-decay process in the photocycle of photoactive yellow protein. J Biochem (2002) 0.83

Cardiovascular disease risk factors other than dyslipidemia. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan - 2012 version. J Atheroscler Thromb (2013) 0.83

Whole genomic analysis reveals the porcine origin of human G9P[19] rotavirus strains Mc323 and Mc345. Infect Genet Evol (2011) 0.83

Protection of mice from Shiga toxin-2 toxemia by mucosal vaccine of Shiga toxin 2B-His with Escherichia coli enterotoxin. Vaccine (2007) 0.83

Isolation of maedi/visna virus from a sheep in Japan. J Vet Med Sci (2013) 0.83

Graves' disease following subacute thyroiditis. Tohoku J Exp Med (2011) 0.82

Treatment - therapeutic lifestyle modification. J Atheroscler Thromb (2008) 0.82

Diagnostic criteria for dyslipidemia. J Atheroscler Thromb (2013) 0.82

Primary cardiovascular events and serum lipid levels in elderly Japanese with hypercholesterolemia undergoing 6-year simvastatin treatment: a subanalysis of the Japan lipid intervention trial. J Am Geriatr Soc (2004) 0.82

Molecular epidemiology of G9 rotaviruses in Taiwan between 2000 and 2002. J Clin Microbiol (2006) 0.82

Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000. J Atheroscler Thromb (2005) 0.82

Detection of human group C rotaviruses in Nigeria and sequence analysis of their genes encoding VP4, VP6, and VP7 proteins. J Med Virol (2002) 0.82

Treatment B) drug therapy: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb (2013) 0.82

Treatment A) lifestyle modification: executive summary of the Japan Atherosclerosis Society(JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version. J Atheroscler Thromb (2013) 0.81

P19 embryonal carcinoma cells exhibit high sensitivity to botulinum type C and D/C mosaic neurotoxins. Microbiol Immunol (2012) 0.81